Preliminary Exploration of the Protective Mechanism of Eugenol Against Acute Liver Injury Induced by Thioacetamide Based on Metabolomics

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2024 Nov 27

PMID 39598677

Authors

Huanghan Chen

Mengting Li

Hongmu Yan

Jingyu Yan

Guang Wang

Lina Gao

Affiliations

Soon will be listed here.

Abstract

Acute liver injury (ALI) is a significant global public health issue that can rapidly develop into acute liver failure, seriously endangering the safety of patients. Eugenol has various pharmacological effects such as antioxidant, anti-inflammatory, antibacterial, and neuroprotective properties. Through pathological section observation, eugenol can alleviate the degree of liver damage caused by thioacetamide. Based on metabolomics, a total of 87 metabolites were found to have differences in content between the control group and the thioacetamide group. Compared with the control group, the contents of 42 metabolites had increased and 45 metabolites had decreased in the thioacetamide group. These differential expressed metabolites mainly indicate inflammatory damage, oxidative damage, and abnormal energy metabolism. There were 269 metabolites with differences in content between the eugenol intervention group and the thioacetamide group. Compared with the thioacetamide group, there were 101 metabolites with increased content and 168 metabolites with decreased content in the eugenol intervention group. These differential expressed metabolites suggest that eugenol intervention can correct inflammation damage, oxidative damage, and energy metabolism abnormalities caused by TAA. This study found through pathological section observation and metabolomics that eugenol has a protective effect on acute liver injury caused by thioacetamide, and the protective mechanism may be related to the antioxidant and anti-inflammatory effects of eugenol.

References

Ulanowska M, Olas B . Biological Properties and Prospects for the Application of Eugenol-A Review. Int J Mol Sci. 2021; 22(7). PMC: 8036490. DOI: 10.3390/ijms22073671. View

Elnfarawy A, Nashy A, Abozaid A, Komber I, Elweshahy R, Abdelrahman R . Vinpocetine attenuates thioacetamide-induced liver fibrosis in rats. Hum Exp Toxicol. 2020; 40(2):355-368. DOI: 10.1177/0960327120947453. View

Porto M, Silva G, Luperini B, Bachiega T, de Castro Marcondes J, Sforcin J . Citral and eugenol modulate DNA damage and pro-inflammatory mediator genes in murine peritoneal macrophages. Mol Biol Rep. 2014; 41(11):7043-51. DOI: 10.1007/s11033-014-3657-9. View

Radhakrishnan A, Tudawe D, Chakravarthi S, Chiew G, Haleagrahara N . Effect of γ-tocotrienol in counteracting oxidative stress and joint damage in collagen-induced arthritis in rats. Exp Ther Med. 2014; 7(5):1408-1414. PMC: 3991526. DOI: 10.3892/etm.2014.1592. View

Ezhilarasan D . Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models. Environ Toxicol Pharmacol. 2023; 99:104093. DOI: 10.1016/j.etap.2023.104093. View

Nishi K, Yagi H, Ohtomo M, Nagata S, Udagawa D, Tsuchida T . A thioacetamide-induced liver fibrosis model for pre-clinical studies in microminipig. Sci Rep. 2023; 13(1):14996. PMC: 10495379. DOI: 10.1038/s41598-023-42144-8. View

Ali S, Prasad R, Mahmood A, Routray I, Shinkafi T, Sahin K . Eugenol-rich Fraction of Syzygium aromaticum (Clove) Reverses Biochemical and Histopathological Changes in Liver Cirrhosis and Inhibits Hepatic Cell Proliferation. J Cancer Prev. 2015; 19(4):288-300. PMC: 4285960. DOI: 10.15430/JCP.2014.19.4.288. View

Chan C, Cheng L, Lu J, Huang Y, Chiou S, Tsai P . The role of interferon-γ inducible protein-10 in a mouse model of acute liver injury post induced pluripotent stem cells transplantation. PLoS One. 2012; 7(12):e50577. PMC: 3515611. DOI: 10.1371/journal.pone.0050577. View

Duan Y, Duan J, Feng Y, Huang X, Fan W, Wang K . Hepatoprotective Activity of Vitamin E and Metallothionein in Cadmium-Induced Liver Injury in . Oxid Med Cell Longev. 2018; 2018:9506543. PMC: 5924983. DOI: 10.1155/2018/9506543. View

10.

Shastry A, Dunham-Snary K . Metabolomics and mitochondrial dysfunction in cardiometabolic disease. Life Sci. 2023; 333:122137. DOI: 10.1016/j.lfs.2023.122137. View

11.

Xiao G, Xu A, Jiang J, Chen Z, Li Y, Li S . Metabolomics analysis delineates the therapeutic effects of Yinlan Tiaozhi capsule on triton WR-1339 -induced hyperlipidemia in mice. Front Pharmacol. 2023; 14:1252146. PMC: 10642944. DOI: 10.3389/fphar.2023.1252146. View

12.

Schrimpe-Rutledge A, Codreanu S, Sherrod S, McLean J . Untargeted Metabolomics Strategies-Challenges and Emerging Directions. J Am Soc Mass Spectrom. 2016; 27(12):1897-1905. PMC: 5110944. DOI: 10.1007/s13361-016-1469-y. View

13.

Kim S, Oh O, Min H, Park E, Kim Y, Park H . Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Life Sci. 2003; 73(3):337-48. DOI: 10.1016/s0024-3205(03)00288-1. View

14.

Chniguir A, Saguem M, Dang P, El-Benna J, Bachoual R . Eugenol Inhibits Neutrophils Myeloperoxidase In Vitro and Attenuates LPS-Induced Lung Inflammation in Mice. Pharmaceuticals (Basel). 2024; 17(4). PMC: 11054673. DOI: 10.3390/ph17040504. View

15.

Wang F, Fan J, Zhang Z, Gao B, Wang H . The global burden of liver disease: the major impact of China. Hepatology. 2014; 60(6):2099-108. PMC: 4867229. DOI: 10.1002/hep.27406. View

16.

Jaeschke H, Akakpo J, Umbaugh D, Ramachandran A . Novel Therapeutic Approaches Against Acetaminophen-induced Liver Injury and Acute Liver Failure. Toxicol Sci. 2020; 174(2):159-167. PMC: 7098369. DOI: 10.1093/toxsci/kfaa002. View

17.

Enciso N, Amiel J, Fabian-Dominguez F, Pando J, Rojas N, Cisneros-Huamani C . Model of Liver Fibrosis Induction by Thioacetamide in Rats for Regenerative Therapy Studies. Anal Cell Pathol (Amst). 2022; 2022:2841894. PMC: 9675604. DOI: 10.1155/2022/2841894. View

18.

Ta N, A L, E E, Qi R, Mu X, Feng L . Metabolomics analysis reveals amelioration effects of yellowhorn tea extract on hyperlipidemia, inflammation, and oxidative stress in high-fat diet-fed mice. Front Nutr. 2023; 10:1087256. PMC: 9894254. DOI: 10.3389/fnut.2023.1087256. View

19.

Singer G, Zielsdorf S, Fleetwood V, Alvey N, Cohen E, Eswaran S . Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation. Transplant Proc. 2015; 47(2):478-84. DOI: 10.1016/j.transproceed.2014.11.029. View

20.

Sies H . Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997; 82(2):291-5. DOI: 10.1113/expphysiol.1997.sp004024. View